it is very cheap if just left with iridium stake and no debt.
it is not cheap if ful left with iridium stake and the USD$ 10 mill debt that the previously debt-free iridium stake was used as collateral for, even though this debt was only ever used to fund instantaneously worthless health assets (given they were written down to zero after 6 months by the company)